ImageneBio Inc

NASDAQ:IMA

Biotechnology

Healthcare
$4.61 +6.06%

+$0.35 today

Market cap
$52.00M
Beta
0.72
P/E (TTM)
-1.5
EPS (TTM)
-$4.02
52W Low $3.94High $18.00

Volume 0.00M

Average 0.35M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$47.84M

FY 2025 · Annual

Investing Cash Flow

-$5.81M

FY 2025 · Annual

Financing Cash Flow

$135.47M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(34.12M)(68.77M)(68.17M)(49.23M)(52.4M)
Depreciation & Amortization544K751K1.02M490K328K
Deferred Income Tax00000
Stock-Based Compensation5.18M7.53M05.3M15.39M
Change in Working Capital(33.03M)(15.14M)(21.67M)(3.98M)(19.19M)
Accounts Receivables361K(291K)000
Inventory00000
Accounts Payables00(2.87M)(1.17M)(2.82M)
Other Working Capital(33.39M)(14.85M)(18.8M)(2.81M)(16.37M)
Other Non-Cash Items1.17M1.52M9.07M1.42M8.02M
Operating Cash Flow(60.25M)(74.11M)(79.74M)(46M)(47.84M)
Capital Expenditures(1.76M)(1.43M)(414K)00
Acquisitions (Net)0000(5.22M)
Purchases of Investments0(216.34M)(90.05M)(88.3M)(10.4M)
Sales of Investments0118.49M154.61M60.46M9.8M
Other Investing Activities000(7.07M)0
Investing Cash Flow(1.76M)(99.28M)64.14M(34.9M)(5.81M)
Debt Repayment000015M
Common Stock Issued131.3M037.56M065.84M
Common Stock Repurchased00(663K)00
Dividends Paid00000
Other Financing Activities582K1.1M39.09M054.63M
Financing Cash Flow131.74M1.1M75.98M0135.47M
Effect of Forex Changes00(406K)0604K
Net Change in Cash69.73M(172.3M)59.98M(80.91M)82.41M
Free Cash Flow(62.01M)(75.54M)(80.16M)(46M)(47.84M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$52.4M
+ D&A$328.0K
+ Stock-Based Comp$15.4M
+ Deferred Tax$0
- Working Capital-$19.2M
+ Other Non-Cash$8.0M
= Operating Cash Flow-$47.8M
- Capex$0
= Free Cash Flow-$47.8M

Analysis

FY2025 free cash flow is -$47.8M. FCF conversion is 91.3% of net income. Operating cash flow was -$47.8M, with capex of $0. The largest bridge item is Working Capital at -$19.2M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipAug 17, 2026
4Statement of changes in beneficial ownershipAug 17, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
EFFECTEFFECT filingAug 11, 2026
EFFECTEFFECT filingAug 11, 2026

Does IMA generate free cash flow?

ImageneBio Inc (IMA) generated -$47.84M of free cash flow in fiscal 2025.

How much operating cash flow does IMA produce?

Operating cash flow was -$47.84M, before capital expenditures of $0.00.